A Trial of Micronutrients and Adverse Pregnancy Outcomes

PHASE3CompletedINTERVENTIONAL
Enrollment

8,468

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

December 31, 2004

Study Completion Date

July 31, 2006

Conditions
PregnancyPremature BirthInfant, Low Birth WeightPregnancy Outcomes
Interventions
DIETARY_SUPPLEMENT

Multivitamins-vitamins B-complex, C, and E

One daily oral dose of 20 mg of B1, 20 mg of B2, 25 mg of B6, 100 mg of niacin, 50 mcg of B12, 500 mg of C, and 30 mg of vitamin E from randomization until delivery. Participants may continue taking this intervention until 18 months post-partum if they are re-randomized to it after delivery.

DIETARY_SUPPLEMENT

Placebo

One daily oral dose of a placebo pill taken from randomization until delivery. Participants may continue taking this intervention until 18 months post-partum if they are re-randomized to it after delivery.

All Listed Sponsors
collaborator

Muhimbili University of Health and Allied Sciences

OTHER

lead

Harvard School of Public Health (HSPH)

OTHER

NCT00197548 - A Trial of Micronutrients and Adverse Pregnancy Outcomes | Biotech Hunter | Biotech Hunter